A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George’s, University of London and results published in NEJM Evidence.
Roche wins CE mark for its first CGM
Dive Brief: Roche said Tuesday it has received a CE mark for its Accu-Chek Smartguide continuous glucose monitor (CGM). The clearance positions Roche to challenge
July 10, 2024